The EU-Japan Centre for Industrial Cooperation is organizing their Biotech Mission in Japan from October 7-11, 2024, and is calling for companies to apply. Be one of the 12 selected participants to showcase your business in Osaka, Japan’s historical pharmaceutical powerhouse, followed by the BioJapan Expo in Yokohama. Expand your business, establish new partnerships, and reach new markets with this valuable investment for future growth. The deadline to apply for this exclusive mission is June 6, 2024. The EU-Japan Centre covers all costs related to the mission, while the participating company is expected to cover travel, accommodation, living expenses, and meals.

The mission will start in Osaka on October 7 (Mon) with participation in the EU-Japan Biotech and Pharma Partnering Conference, a one-day partnering event, followed by a site visit on October 8 (Tue), organised in collaboration with local authorities and biotech clusters in the Osaka region, Japan’s second largest Biotech & Pharma Ecosystem and historical Centre of Drug discovery in Japan.

From Wednesday, the mission participants will exhibit and participate in BioJapan 2024 in Yokohama, Japan’s largest and most recognised trade fair focused on biotech, life sciences and pharma. This three-day exhibition and partnering event, from October 9 (Wed) to October 11 (Fri), is an excellent opportunity to engage in B2B meetings in the dedicated partnering area. At a joint EU-Japan Centre booth in the exhibition area, Japanese-language posters will be provided based on the materials from mission participants, and Centre staff and professional interpreters will help to promote mission participants’ products, technologies and assure maximum exposure with visitors of the exhibition. Networking events in the evening will increase the opportunities to connect with potential business partners and clients.

Prior to the mission, a briefing webinar will be organised to prepare for the Japanese market, and access to online partnering opportunities will be provided.

Find more information here.